SARS-CoV-2 induced an overexpression of PD-L1 in epithelial cells, and it was dysregulated in a variety of immune cells including neutrophils, gamma delta T cells, monocytes, and CD4+ T cells of COVID-19 patients (116). This evidence concerns the gene CD4 and COVID-19.